|
Market Closed -
NYSE
16:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 2.360 USD | -9.92% |
|
-3.28% | +31.11% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -9.92% | -3.28% | -1.26% | +22.28% | +31.11% | +46.58% | +22.92% | +76.12% | -62.25% | 190M | |
| -0.92% | +1.43% | +2.30% | +19.03% | +12.50% | +83.05% | +128.86% | +357.59% | +1,407.11% | 1,078B | |
| +0.47% | +1.98% | +1.67% | +13.74% | +26.64% | +50.26% | +50.75% | +48.70% | +112.69% | 632B | |
| +0.83% | +2.85% | +1.14% | +20.30% | +9.77% | +24.49% | +64.82% | +115.33% | +273.30% | 443B | |
| -2.01% | -3.10% | +8.84% | +10.25% | +8.44% | +42.30% | +34.38% | -3.38% | +43.05% | 356B | |
| -1.65% | -3.10% | -0.28% | +4.63% | +11.39% | +23.85% | +34.27% | +42.10% | +52.03% | 289B | |
| -1.71% | -3.19% | -6.86% | -16.19% | -16.49% | -0.60% | +3.62% | +35.85% | +123.87% | 245B | |
| +0.40% | +3.21% | +15.92% | +24.19% | +27.66% | +44.42% | +59.17% | +81.92% | +141.50% | 226B | |
| +0.43% | -1.77% | -6.26% | +4.79% | -7.86% | -7.64% | -51.61% | -7.63% | +92.61% | 204B | |
| +1.67% | +5.56% | +5.13% | +3.83% | +12.55% | +14.98% | +72.68% | +94.13% | +73.41% | 171B | |
| +1.86% | +2.29% | +9.48% | +3.24% | +7.63% | +6.52% | -25.64% | -44.72% | -23.38% | 153B | |
| -1.77% | +6.70% | +7.54% | +13.99% | +13.91% | +30.44% | +47.61% | +165.71% | +408.66% | 131B | |
| +1.49% | +0.78% | +8.95% | +14.65% | +19.86% | +35.11% | +5.59% | -4.24% | +6.63% | 132B | |
| -1.16% | +0.27% | +0.01% | +3.10% | -8.72% | -9.61% | -22.64% | -14.24% | +5.18% | 106B | |
| -2.26% | -7.40% | -5.48% | -3.05% | -0.50% | +28.29% | +30.98% | -3.13% | -15.17% | 100B | |
| -3.37% | +1.11% | -4.25% | -14.37% | -15.89% | +13.08% | +62.90% | +72.63% | +485.89% | 74.07B | |
| +0.94% | +1.28% | +5.33% | +6.75% | +16.05% | +28.52% | +26.17% | +54.23% | +18.95% | 55.7B | |
| -1.24% | -4.46% | -3.11% | +24.65% | +28.59% | +78.71% | -9.71% | -0.35% | -51.75% | 54.47B | |
| -1.10% | +3.17% | -3.57% | -3.76% | -9.75% | -14.14% | +37.14% | -4.90% | +223.70% | 52.51B | |
| -0.15% | -3.14% | -0.69% | +8.72% | -4.54% | -0.03% | +6.03% | - | - | 42.55B | |
| Average | -1.25% | +0.93% | +1.73% | +8.04% | +8.12% | +25.93% | +28.91% | +55.88% | +174.53% | 227.25B | |
| Weighted average by Cap. | -0.65% | +1.35% | +2.48% | +11.31% | +10.76% | +40.16% | +54.91% | +120.09% | +428.35% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
